DRIVE-AB congratulates Work Package 1A partner Céline Pulcini on receiving the prestigious European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Young Investigator Award. Pulcini, a professor in infectious diseases in Nancy, France is not only an integral member of the DRIVE-AB WP1A team, responsible use of antibiotics, new and old, but is also secretary of (the ESCMID Study Group for Antibiotic Policies), and coordinates the Antimicrobial Stewardship working group of the French infectious diseases society (SPILF). Céline will officially receive her award during the...Read more
DRIVE-AB partner Prof Otto Cars, Uppsala University, has been formally nominated by the United Nations (UN) Secretary General to serve as an expert to the UN ad-hoc Interagency Coordination Group on Antimicrobial Resistance (ICG-AMR). The group is currently being established in response to the UN Declaration to combat AMR that was made in September 2016 to provide practical guidance on action to address the issue of AMR globally and to supervise the implementation of the commitments and tasks that were mandated in the Declaration. Click here to read more on this story.
The World Health Organization (WHO), with some assistance from DRIVE-AB, among others, has recently published their first ever Priority Pathogen List: a catalogue of 12 antibiotic-resistant families of bacteria that pose the greatest threat to human health. The catalogue was developed to guide and promote research and development of new antibiotics as part of the WHO's efforts to address the global threat of antibiotic resistance. Epidemiological data derived from the work of DRIVE-AB Work Package 1B, "Setting, communicating and revising public health priorities", was used as basis for evidence-based criteria for the List. To read more from...Read more
The Boston Consulting Group (BCG) has published a follow-up report for the German Global Union for Antibiotics Research and Development (GUARD) Initiative, “Breaking through the wall: A call for concerted action on antibiotics research and development” in February 2017. It provides detail on four key levers as possible actionable policy instruments; target product profiles, a global research fund, a global development fund and a global launch reward. Click here to read the full report. ...Read more
In mid-December 2016 the World Health Organization (WHO) established an Antimicrobial Resistance (AMR) Surveillance and Quality Assessment Collaborating Centres Network with a remit to support the development and improvement of global AMR surveillance capacity. The network members are drawn from 18 WHO Collaborating Centres and are responsible for the implementation of the 2017-2019 work plan. Four priority areas of work in this plan include,Read more
- capacity building and technical support to microbiology laboratories,
- capacity building and technical support to surveillance systems,
- global AMR Surveillance System (GLASS) development,
- and increasing the understanding of the impact of AMR.